Get every episode summarized
Each time Barron's Streetwise publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
About this episode
BMO Capital Markets analyst Evan Seigerman discusses the Trump Administration's deal with Big Pharma. Plus, meet the Suspicious 8, with 6% dividends and lots of problems.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Get every episode summarized
Each time Barron's Streetwise publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Barron's Streetwise
Roller Coasters, REITs, and Rotten Tomatoes
Barron's Streetwise
Will Bond Vigilantes Tank the Stock Market?
Barron's Streetwise
Oracle and Oil Refiners. Plus, Pyramid Scheme or Nah?
Barron's Streetwise
Ode to BJ’s Wholesale
Barron's Streetwise